High Quality Reagents for Arthritis & Inflammation Research

AMSBIO has announced a pan European partnership with Chondrex Inc. to market their high quality arthritis and inflammation reagents to academics and pharmaceutical companies that do research in these fields.

The range includes a suite of high quality reagents such as highly purified cartilage collagen and collagen monoclonal antibodies to provide scientists with the necessary tools to study the pathogenesis as well as to develop and screen potential therapeutics for Rheumatoid Arthritis (RA).  In addition, AMSBIO has also improved its capability to provide reagents and various assay kits for the investigation of other important inflammatory diseases such as nephritis and allergic asthma.

Multi species Collagen reactive antibodies are available that can be used in western blotting, immunostaining and for inducing Collagen Antibody-Induced Arthritis (CAIA).

Collagenases, members of the matrix metalloproteinase (MMP) family, are involved in the physiological and pathological turnover of connective tissues. Collagenase production is significantly increased at the sites of inflammation due to the stimulation of pro-inflammatory cytokines. AMSBIO is now able to provide recombinant human MMP-8 and MMP-13, in addition to collagenase assay kits using FITC-labeled type I collagen and type II collagen, or a fluorogenic peptide as substrates.  The new AMSBIO arthritis & inflammation research reagent range also includes type I and type II collagen specially purified for antibody assay by ELISA.

For a catalogue detailing this exciting new range of high quality reagents for arthritis & inflammation research please visit http://www.amsbio.com/partners_chondrex.aspx or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com